Recent efficacy and long-term survival of Astragalus polysaccharide combined with gemcitabine and S-1 in pancreatic cancer

Table 3 Immune function (%, mean ± SD)

Indicators	CD3+	CD4+	CD8+	CD4+/CD8+	IL-2 (pg/mL)	INF-γ (pg/mL)
APS + GS (n = 41)	50.18 ± 9.57	31.52 ± 5.33	18.65 ± 6.37	1.69 ± 0.21	3.30 ± 0.83	12.64 ± 4.90
GS regimen (n = 56)	44.06 ± 8.55	26.01 ± 7.83	18.06 ± 3.80	1.44 ± 0.21	2.67 ± 0.51	11.55 ± 3.70
t value	3.307	3.886	0.576	5.852	4.581	1.253
P value	0.001	0.000	0.566	0.000	0.000	0.213

APS: Astragalus polysaccharide; GS: Gemcitabine plus tegafur gimeracil oteracil potassium capsule (S-1); IFN-γ: Interferon-γ; IL-2: Interleukin-2.